Total Payments
$794.96
2023 Payments
$52.73
Companies
12
Transactions
24
Medicare Patients
4,656
Medicare Billing
$606,946
Payment Breakdown by Category
Food & Beverage$794.96 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $794.96 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Coloplast Corp | $301.57 | 8 | $0 (2023) |
| NeoTract Inc. | $146.82 | 1 | $0 (2019) |
| Philips Electronics North America Corporation | $82.83 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $53.46 | 4 | $0 (2017) |
| Cogentix Medical Inc. | $52.92 | 1 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $32.35 | 2 | $0 (2018) |
| DENTSPLY IH AB | $28.69 | 1 | $0 (2023) |
| 180 Medical, Inc. | $25.98 | 2 | $0 (2019) |
| Amgen Inc. | $21.09 | 1 | $0 (2017) |
| Avadel Specialty Pharmaceuticals, LLC | $19.45 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $52.73 | 2 | DENTSPLY IH AB ($28.69) |
| 2022 | $24.21 | 1 | Coloplast Corp ($24.21) |
| 2021 | $86.47 | 3 | COLOPLAST CORP ($86.47) |
| 2020 | $172.56 | 3 | Coloplast Corp ($155.52) |
| 2019 | $183.88 | 4 | NeoTract Inc. ($146.82) |
| 2018 | $134.63 | 4 | Philips Electronics North America Corporation ($82.83) |
| 2017 | $140.48 | 7 | Astellas Pharma US Inc ($53.46) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2023 | DENTSPLY IH AB | LoFric (Device) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: Medical Urology | ||||||
| 05/12/2023 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Continence Care | ||||||
| 01/26/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Continence Care | ||||||
| 12/15/2021 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Continence Care | ||||||
| 11/19/2021 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Continence Care | ||||||
| 11/08/2021 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $48.68 | General |
| Category: Continence Care | ||||||
| 05/05/2020 | Coloplast Corp | CONTINENCE CARE (Device) | Food and Beverage | Cash or cash equivalent | $29.16 | General |
| Category: CONTINENCE | ||||||
| 02/13/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 02/06/2020 | Coloplast Corp | SPEEDICATH (Device) | Food and Beverage | Cash or cash equivalent | $126.36 | General |
| Category: CONTINENCE | ||||||
| 12/05/2019 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $146.82 | General |
| Category: Interventional Urology | ||||||
| 11/18/2019 | DENTSPLY IH Inc. | LoFric (Device) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Medical Urology | ||||||
| 03/15/2019 | Coloplast Corp | SPEEDICATH (Device) | Food and Beverage | Cash or cash equivalent | $11.33 | General |
| Category: CONTINENCE | ||||||
| 02/22/2019 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | Cash or cash equivalent | $12.97 | General |
| Category: CONTINENCE AND CRITICAL CARE | ||||||
| 07/23/2018 | Philips Electronics North America Corporation | Uronav (Device) | Food and Beverage | Cash or cash equivalent | $82.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/31/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Oncology | ||||||
| 03/30/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Urology | ||||||
| 03/27/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Oncology | ||||||
| 12/07/2017 | 180 Medical, Inc. | — | Food and Beverage | Cash or cash equivalent | $13.01 | General |
| 04/20/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Xtandi | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Urology | ||||||
| 03/22/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Oncology | ||||||
| 03/03/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Endocrinology | ||||||
| 02/13/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Xtandi | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Urology | ||||||
| 01/20/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Xtandi | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Urology | ||||||
| 01/06/2017 | Cogentix Medical Inc. | Urgent PC (Device), Macroplastique, PrimeSight | Food and Beverage | Cash or cash equivalent | $52.92 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 19 | 1,202 | 6,398 | $491,338 | $174,855 |
| 2021 | 20 | 1,703 | 7,519 | $618,798 | $216,472 |
| 2020 | 29 | 1,751 | 7,510 | $639,214 | $215,620 |
Total Patients
4,656
Total Services
21,427
Medicare Billing
$606,946
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 18 | 4,740 | $142,200 | $81,094 | 57.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 17 | 162 | $129,600 | $22,453 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 234 | 316 | $45,504 | $18,446 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 170 | $35,530 | $14,885 | 41.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 64 | 79 | $41,475 | $13,174 | 31.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 20 | 22 | $22,220 | $6,892 | 31.0% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 46 | 46 | $15,338 | $3,975 | 25.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 152 | 179 | $14,678 | $3,248 | 22.1% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 17 | 38 | $7,600 | $2,116 | 27.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $6,180 | $1,948 | 31.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 50 | 50 | $6,545 | $1,476 | 22.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 12 | 36 | $6,876 | $1,443 | 21.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 46 | 46 | $6,943 | $1,019 | 14.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 17 | 30 | $2,760 | $738.00 | 26.7% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 25 | 34 | $2,006 | $629.28 | 31.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 171 | 202 | $2,222 | $597.30 | 26.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 76 | 102 | $1,428 | $319.80 | 22.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 26 | 29 | $1,363 | $207.93 | 15.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 52 | 87 | $870.00 | $193.06 | 22.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 18 | 5,220 | $156,600 | $85,765 | 54.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 18 | 192 | $153,600 | $27,346 | 17.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 368 | 464 | $66,816 | $27,254 | 40.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 217 | 277 | $57,893 | $23,137 | 40.0% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 103 | 125 | $65,625 | $20,560 | 31.3% |
| 52356 | Crushing of stone in urinary duct (ureter) with stent using an endoscope | Facility | 2021 | 22 | 24 | $24,240 | $7,181 | 29.6% |
About Dr. Robert Devore, MD
Dr. Robert Devore, MD is a Urology healthcare provider based in Greer, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023092699.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Devore, MD has received a total of $794.96 in payments from pharmaceutical and medical device companies, with $52.73 received in 2023. These payments were reported across 24 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($794.96).
As a Medicare-enrolled provider, Devore has provided services to 4,656 Medicare beneficiaries, totaling 21,427 services with total Medicare billing of $606,946. Data is available for 3 years (2020–2022), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Greer, SC
- Active Since 12/06/2005
- Last Updated 02/02/2018
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1023092699
Products in Payments
- UroLift (Device) $146.82
- SPEEDICATH (Device) $137.69
- SpeediCath (Device) $134.72
- Uronav (Device) $82.83
- Urgent PC (Device) $52.92
- Myrbetriq (Drug) $42.59
- LoFric (Device) $41.45
- Xofigo (Drug) $32.35
- CONTINENCE CARE (Device) $29.16
- Prolia (Biological) $21.09
- Noctiva (Drug) $19.45
- PROVENGE (Drug) $17.04
- GENTLECATH (Device) $12.97
- Xtandi (Drug) $10.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.